Stockreport

Why Sarepta Therapeutics (SRPT) Is Down 11.2% After CEO Retirement Plan And Japan Gene Therapy Launch - And What's Next [Yahoo! Finance]

Sarepta Therapeutics, Inc.  (SRPT) 
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF CEO Douglas Ingram notified the company of his plan to retire by the end of 2026 or upon appointment of a successor. At the same time, Sarepta and partner Chugai launc [Read more]